Maria Chiara Fiorentino is a Research Fellow at the Department of Information Engineering, Polytechnic University of Marche, Italy. Her work focuses on applying deep learning techniques to medical image analysis, particularly in ultrasound, MRI, and CT imaging. Education Master’s in Biomedical Engineering, Università Politecnica delle Marche (Honors) Ph.D. in Information Engineering, Università Politecnica delle Marche (Laude) Research Interests: Dr. Fiorentino specializes in deep learning for medical imaging, with applications in diagnosing neurodegenerative diseases like Parkinson’s, cardiovascular conditions, and musculoskeletal disorders. Her recent work includes federated learning for fetal ultrasound analysis, AI-driven vocal fold pose estimation, and domain adaptation in MRI segmentation. Scientific Awards: Paolo Marziali Thesis Prize for her Master’s research Gruppo Nazionale di Bioingegneria award for her Ph.D. thesis Publications: Dr. Fiorentino’s work spans fetal brain image synthesis, zero-shot learning robustness, and machine learning for catheterization management and stenosis detection.
Dr. Sharib Ali is a Lecturer (Assistant Professor) in the School of Computer Science at the University of Leeds, Faculty of Engineering and Physical Sciences. He is affiliated with the Leeds Cancer Research Centre and actively contributes to research in biomedical image analysis and computer vision. His work bridges cutting-edge AI with clinical applications, particularly in endoscopy and surgical technologies. PhD in Medical Image Analysis, University of Lorraine, France MSc in Computer Vision (by research), University of Burgundy, France Dr. Ali's research focuses on biomedical image analysis , computer vision , and machine learning , with applications in early cancer detection , computational endoscopy , and 3D reconstruction . He develops robust algorithms for segmentation, registration, depth estimation, and mosaicking, using both classical mathematical models and deep learning. His work emphasizes translational research and generalisability in real-world clinical settings. The recent publications highlight a strong trend in generalisability assessment , multi-modal data fusion , and AI benchmarking in endoscopy. His work spans from foundational algorithm development to clinical deployment, including federated learning , mixed reality in surgery , and multi-centre datasets , addressing key challenges like bias, data imbalance, and privacy. Dr. Ali has co-supervised multiple DPhil/PhD students and currently supervises several PhD candidates at the University of Leeds, University of Oxford, and Tec de Monterrey. He is actively involved in securing research funding and leading projects such as Leveraging multi-modality data for targeted biopsy and Federated learning in healthcare . He is a founding member of NAAMII, Nepal, where he volunteers to train students from LMICs. He also organizes international research initiatives including the EndoCV and P2ILF challenges at MICCAI, and serves on program committees and as a reviewer for journals like Nature Communications and Medical Image Analysis . His research is conducted within interdisciplinary teams, collaborating with clinicians from Oxford NHS University Hospitals, neuroscientists at Forschungszentrum Jülich, and engineers across Europe. He leads the development of open tools and datasets to advance the field of endoscopic computer vision.
Katie T. Anderson, M.D. is an Assistant Professor of Urology at Mayo Clinic in Rochester, Minnesota, serving as a Consultant in the Department of Urology. She holds leadership roles as Associate Program Director for the Trauma and Genitourinary Reconstructive Surgery Fellowship (2023-present) and Director of Simulation Education for the Department of Urology (2022-present). Dr. Anderson specializes in genitourinary trauma and reconstruction, with clinical expertise in neurogenic bladder, urethral stricture disease, and acquired buried penis. Fellowship - Genitourinary Reconstructive Surgery, University of Minnesota Medical Center (2020) Residency - Urologic Surgery, University of Pittsburgh Medical Center (2019) Internship - General Surgery, University of Pittsburgh Medical Center (2015) Doctorate of Medicine, University of Minnesota Medical School (2013) BS, University of St. Thomas (2009) Dr. Anderson's research program focuses on advancing quality of life for patients with neurogenic bladder, developing strategies to prevent soft tissue damage following pelvic radiation, and understanding imposter phenomenon's impact on urologist burnout. Her work includes evaluating frailty's relationship to bladder augmentation outcomes, standardizing surgical approaches for acquired buried penis, and establishing long-term quality-of-life data following urinary diversions. She leads multi-institutional studies examining radiation cystitis treatments and quality-of-life outcomes. Her recent publications demonstrate a cohesive research trajectory centered on surgical outcomes, quality improvement, and physician wellness. Analysis of her 15 most recent articles reveals strong emphasis on technical innovations in urethroplasty, urinary diversion standardization, and the critical intersection of mental health and surgical practice. A distinctive contribution is her investigation into imposter phenomenon among urologists, addressing a previously underexplored factor in physician burnout and career longevity. 2023 Hall of Fame Inductee, University of Saint Thomas 2023 Best Podium Presentation: 'Variability in surgical codes in the treatment of adult acquired buried penis,' Genitourinary Reconstructive Surgeons 2022 Best Video Abstract Award, North Central Section of American Urologic Association 2021 NCS Traveling Fellowship Award, North Central Section - American Urological Association 2020 Best Poster Award: 'Frequent of patient-reported UTIs predicts quality of life after SCI,' AUA Annual Meeting As Director of Simulation Education, Dr. Anderson oversees advanced training programs for urology residents and fellows. Her leadership in the Trauma and Genitourinary Reconstructive Surgery Fellowship program demonstrates commitment to developing the next generation of specialists. She has secured research support through professional society mechanisms including the Genitourinary Reconstructive Surgeons Traveling Fellow Scholarship, enabling her multi-institutional studies on quality-of-life outcomes and radiation cystitis treatments. Her work on opioid-free surgical pathways reflects innovative approaches to patient care in the context of the national opioid crisis.
Iwan Schie serves as Working Group Leader at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany, where he leads the Spectroscopy / Imaging Multimodal Instrumentation research group. His work bridges analytical chemistry, biomedical engineering, and clinical applications with a focus on developing Raman spectroscopy-based diagnostic tools. Dr. Schie maintains an active research program with numerous publications in high-impact journals across multiple disciplines. Dr. Schie's research centers on Raman spectroscopy applications in medical diagnostics and environmental monitoring. His work demonstrates particular expertise in developing multimodal imaging systems that combine Raman spectroscopy with complementary techniques like optical coherence tomography and fluorescence imaging. His research spans both fundamental methodological development and clinical translation, with several studies focusing on cancer diagnostics across multiple organ systems including head and neck, bladder, and colon cancers. The environmental applications of his work include microplastic detection and pollen analysis. Analysis of Dr. Schie's publication record reveals a clear trajectory toward clinical implementation of Raman spectroscopy technologies. His recent work increasingly focuses on regulatory-compliant medical device development, with multiple studies conducted in accordance with European Medical Device Regulation standards. The publications demonstrate progression from ex vivo validation studies to in vivo clinical applications, with particular emphasis on workflow integration within surgical settings. His collaborative approach is evident through extensive co-authorship networks spanning physics, engineering, and clinical medicine. Dr. Schie has made significant contributions to advancing Raman spectroscopy methodology, with publications addressing critical challenges in device stability, spectral analysis, and multimodal integration. His work on establishing clinical workflows represents important steps toward routine clinical adoption of these technologies. The practical impact of his research is demonstrated through development of systems like the invaScope Raman endoscopy platform for bladder tumor diagnosis. As Working Group Leader at Leibniz-IPHT, Dr. Schie oversees research activities in spectroscopy and multimodal imaging instrumentation. His team develops advanced optical systems for biomedical applications with particular focus on real-time tissue characterization during surgical procedures. The research environment supports both fundamental methodological development and applied clinical translation, with strong emphasis on regulatory compliance for medical device development.
Professor Prokar Dasgupta serves as Chair in Robotic Surgery & Honorary Consultant Urological Surgeon at King's College London's School of Medicine, specifically within the Peter Gorer Department of Immunobiology. He is a pioneering figure in robotic urological surgery in the UK and serves as Editor-in-Chief of the British Journal of Urology International (BJUI) since 2013. As theme lead for Experimental Surgery within King's Health Partners, he oversees significant translational research initiatives within one of the UK's largest Academic Health Sciences Centers. Professor Dasgupta's research spans multiple cutting-edge domains in urological surgery. His primary focus includes robotics in urology with scientific evaluation of procedures, stem cell and cell-targeted therapies for prostate and bladder cancer, bladder physiology research focusing on receptors like TRPV1 and P2X3, and innovative applications of botulinum toxin for overactive bladders. His work integrates engineering principles with clinical practice, developing mechatronic sensors, augmented reality systems, and 3D planning tools to enhance robotic surgical precision. His research group employs advanced techniques including micro-array technology, real-time PCR, and immunohistochemistry in both human tissues and animal models. Analysis of Professor Dasgupta's recent publications reveals a strong trend toward integrating artificial intelligence with robotic surgery. His work increasingly focuses on surgical workflow analysis, video recognition systems, and overcoming technical limitations in telesurgery. The publications demonstrate his leadership in both clinical applications of robotics and the underlying technological innovations that enable more precise surgical interventions. His research bridges engineering, computer science, and clinical urology to address fundamental challenges in surgical practice. His scientific recognition includes the prestigious Karl Storz-Harold Hopkins Golden Telescope award from the British Association of Urological Surgeons for significant contributions to urology, along with multiple awards for educational contributions including Best Oral Presentations and Best Posters in surgical education. He has been consistently recognized as one of BJUI's top reviewers. Professor Dasgupta has secured approximately £70 million through 36 research grants from major funding bodies including EUFP7, MRC, MS Society, and BUF. He leads a 28-strong multidisciplinary team comprising basic scientists, engineers, and clinician-scientists at King's College London. His supervisory role extends across numerous PhD students and research fellows, contributing to the 84 PhD students supervised by the 41 principal investigators within his division. His educational contributions include serving as tutor for MSc and FRCS (Urol) courses and as an examiner for the University of London. His research environment includes active collaboration with the Wellcome/EPSRC Centre for Medical Engineering and leadership in several major projects including AI-driven surgical skills acquisition, international AI research ecosystems, and innovative prostate cancer treatment trials. His laboratory work integrates robotics, imaging technology, and molecular biology to advance precision surgery in urological oncology.
Jane T. Kurtzman, MD, serves as an Assistant Professor in the Department of Surgery at the University of Utah, specializing in urology with dual clinical focus on adult reconstructive urology and gender-affirming surgical care. She practices at the University of Utah Hospital Urology Clinic and leads innovative global health initiatives through GU-IMPACTS, a multi-institutional program providing longitudinal urology training in Rwanda and Cambodia. Her educational trajectory includes: B.A. in Anthropology and Religion from Dartmouth College M.D. from SUNY Downstate College of Medicine General Surgery Internship at NewYork-Presbyterian Hospital, Columbia University Irving Medical Center Urology Residency at NewYork-Presbyterian Hospital, Columbia University Irving Medical Center Genitourinary Injury and Reconstruction Fellowship at the University of Utah Dr. Kurtzman's research program centers on complex reconstructive challenges including radiation-induced injuries, neurogenic bladder management, and urethral stricture disease, with particular emphasis on surgical innovation for high-risk patients. Her gender-affirming surgery expertise addresses critical gaps in transgender healthcare, while her global health work through GU-IMPACTS develops sustainable training models for urologic care in resource-limited settings. Recent publications demonstrate methodological rigor across clinical outcomes research, surgical technique refinement, and healthcare equity analysis. Analysis of her 15 most recent publications (2018-2023) reveals three dominant research vectors: (1) Technical innovation in urethroplasty and artificial urinary sphincter placement with focus on graft selection and complication prevention; (2) Healthcare disparities research examining bias in patient satisfaction metrics and access barriers to reconstructive procedures; (3) Global surgery capacity building through curriculum development and outcomes assessment in low-resource settings. Her work consistently bridges clinical practice with systems-level improvements. As Co-Founder and Director of GU-IMPACTS, Dr. Kurtzman leads a pioneering effort to establish sustainable urology subspecialty training in Rwanda and Cambodia, addressing critical workforce shortages through longitudinal mentorship. Her clinical practice receives exceptional patient feedback (4.8/5 average from 18 reviews), with consistent praise for her technical expertise, compassionate communication, and commitment to patient-centered care across complex reconstructive cases.
Dr. Shilajit D Kundu serves as Professor of Urology and Chief of Urologic Oncology at Northwestern University Feinberg School of Medicine, holding the Samar Kumar Kundu Professorship. His clinical expertise spans bladder cancer, prostate cancer, kidney cancer, and testicular cancer with specialization in robotic surgery and multimodal therapeutic approaches. Education: MD, University of Illinois, Chicago (2001) Residency, Northwestern University, McGaw Medical Center (2007) Fellowship, Memorial Sloan Kettering Cancer Center (2009) Society of Urologic Oncology Fellowship, Memorial Sloan Kettering Cancer Center (2010) Dr. Kundu's research integrates clinical urologic oncology with psychosocial and genetic investigations. He examines how patient personality, physician-patient relationships, and healthcare environments influence treatment satisfaction, while leading genetic studies to uncover prostate cancer mechanisms in inflammatory bowel disease (IBD) patients. His work bridges molecular analysis with patient-centered outcomes to optimize cancer care pathways. Recent publications reveal evolving trends toward health disparity research (particularly in Black men's prostate cancer screening), immunosuppression-related malignancy risks, and precision surgical outcomes for renal cancers. His scholarly output demonstrates increasing focus on interdisciplinary collaboration between urology, immunology, and behavioral sciences. Scientific Awards: Vincent O' Connor Teaching Award (2023) Chicago Magazine Top Doctors designation (2021-2022) Three-time Outstanding Teacher Award recipient (2018-2021) Chicago Urologic Society Huggins Essay Contest 1st place (2018-2019) Early-career research awards from India Medical Association (1997) Thomas O. Sidebottom Award for senior thesis (1996) Dr. Kundu mentors medical students and residents through Northwestern's urology program, evidenced by multiple teaching accolades. He leads active clinical trials including NCT03558048 investigating IBD flares' impact on prostate-specific antigen levels, with goals to refine prostate cancer screening protocols for IBD patients and reduce unnecessary healthcare utilization. As Chief of Urologic Oncology, he directs a multidisciplinary team within the Department of Urology while maintaining affiliations with the Robert H. Lurie Comprehensive Cancer Center, Institute for Augmented Intelligence in Medicine, and Center for Reproductive Science. His leadership extends to national committees including the American College of Surgeons Operative Standards for Cancer Surgery and North Central Section of the American Urological Association Board of Directors.
Bruce Schlomer, M.D. is a pediatric urologist at Children’s Health and an Assistant Professor of Urology at UT Southwestern Medical Center. His clinical practice spans multiple locations in Dallas, Rockwall, Park Cities, and Texas Scottish Rite Hospital, where he specializes in reconstructive surgery and transitional care for neurogenic bladder patients. Washington University School of Medicine (Medical Degree) UT Southwestern (Urology Residency) University of California San Francisco (Pediatric Urology Fellowship) Dr. Schlomer's research focuses on pediatric genitourinary conditions, including undescended testis , hypospadias , prenatal hydronephrosis , and neurogenic bladder . His recent publications highlight expertise in diagnostic techniques (e.g., near-infrared spectroscopy for testicular torsion), surgical outcomes (bladder neck reconstruction, pyeloplasty), and data analysis methodologies in urology. His work bridges clinical practice with medical education, serving as Director of Resident Pediatric Urology Education at Children’s Medical Center Dallas and contributing to the American Urological Association's Board Review Course and Core Curriculum writing committee. Dr. Schlomer's clinical and research activities emphasize minimizing surgical invasiveness through robotic-assisted procedures and improving transitional care for young adults with chronic urologic conditions.
Dr. Weranja Ranasinghe is an academic urologic-oncology surgeon with joint appointments at Monash University's Faculty of Medicine, Nursing and Health Sciences in the Department of Anatomy & Developmental Biology, and Monash Health. As a Research Fellow, he maintains an active clinical and research presence in the field of urologic oncology with particular expertise in prostate and bladder cancers. His research interests focus on the patho-physiological processes of high risk, lethal and metastatic prostate cancers, pathways leading to treatment resistance, and characterizing the biology of ductal prostate cancers. He investigates pathways driving metastasis development and mechanisms leading to adverse outcomes with conventional therapy. His work spans both clinical and laboratory-based projects, contributing significantly to prostate cancer research. Dr. Ranasinghe's recent publications show a growing interest in the application of artificial intelligence in urology and healthcare, alongside his core focus on prostate cancer biology and treatment. His work demonstrates a trajectory from fundamental cancer biology toward translational applications and technological innovations in diagnosis and treatment. American Urological Association Urology Care Foundation Scholar grant (2019) ANZUP / Astellas 'Best of the best' poster (2012) ANZUP/Bayer Travel Fellowship (2013) ANZUP / Novartis Travel grant (2012) ANZUP Below The Belt Award (2022) Dr. Ranasinghe has established numerous national and international collaborations with researchers, clinicians (urology, radiology, oncology), basic scientists, epidemiologists and statisticians at institutions including MD Anderson (USA), University of Bristol (UK), Latrobe University, and Austin Health. His current projects focus on bladder cancer diagnostics, ductal prostate cancer therapeutics, and urothelial carcinoma monitoring.
Dr. Antoine Khoury is a Professor of Urology at the University of California, Irvine (UCI) School of Medicine and serves as the Chief of Pediatric Urology at CHOC Children’s Urology Center. He holds the Walter R. Schmid Endowed Chair in Pediatric Urology and has over 25 years of clinical and academic leadership experience in pediatric urology. Institution: University of California, Irvine School: School of Medicine Department: Department of Urology Role: Professor and Chief, Pediatric Urology Endowed Chair: Walter R. Schmid Endowed Chair in Pediatric Urology Dr. Khoury completed his medical training at Ain Shams University, residency at the University of Toronto, and fellowship in pediatric urology at The Hospital for Sick Children in Toronto. He previously served as Division Head of Urology at SickKids from 1995 to 2008 before joining UCI and CHOC. His research and clinical interests focus on congenital urological anomalies, including hypospadias, posterior urethral valves, exstrophy-epispadias complex, vesicoureteral reflux, and prenatal hydronephrosis. His scholarly work spans reconstructive surgery, infection control, and biomaterials, with a patent on bioelectric mechanisms to eliminate bacterial biofilms. Dr. Khoury has authored over 200 peer-reviewed publications and 33 book chapters, and has delivered over 250 national and international presentations. His recent publications emphasize clinical reviews and evidence-based management strategies in pediatric urology, particularly in antibiotic prophylaxis, prenatal hydronephrosis, and surgical techniques. American Academy of Pediatrics Section on Urology International Children’s Continence Society Former President, Society of Pediatric Urologists of Canada Immediate Past Chairman, Scientific Council, Canadian Urological Association’s Scholarship Foundation Dr. Khoury has mentored numerous trainees and residents, though specific student names are not listed. He has led significant research initiatives, including clinical trials and outcomes studies in pediatric urology. His work at the University of Calgary on infection and biomaterials led to patented technology. He is fluent in French and Arabic and is actively involved in global academic outreach as a visiting professor. He leads the pediatric urology team at CHOC Children’s, which is dedicated to advanced surgical care, innovation, and research in pediatric genitourinary disorders. The center emphasizes multidisciplinary care, family-centered treatment, and cutting-edge diagnostics and surgical techniques.
Glen A. Lau serves as a Clinical Assistant Professor of Surgery within the Division of Urology at the University of Utah's School of Medicine. He practices pediatric urology across multiple clinical sites including Primary Children's Hospital in Salt Lake City, St. George Regional Hospital, and Utah Valley Outpatient Center. His educational background includes: Bachelor of Science in Neuroscience (Minor: Business Management) from Brigham Young University Doctor of Medicine from University of Toledo College of Medicine Surgical Internship and Urology Residency at University of Tennessee Health Science Center Pediatric Urology Fellowship at University of Utah/Primary Children's Hospital Dr. Lau specializes in pediatric reconstructive urology with particular expertise in endourology, laparoscopy, hypospadias repair, and neurogenic bladder management. His clinical approach emphasizes minimally invasive techniques and innovative solutions for complex congenital anomalies. Current research focuses on optimizing surgical outcomes through evidence-based protocols for renal trauma, neurogenic bladder, and voiding dysfunction. Analysis of his recent publications (2018-2024) reveals three dominant research trajectories: (1) Refinement of reconstructive techniques for hypospadias and bladder neck procedures, (2) Development of standardized protocols for neurogenic bladder management including botulinum toxin therapy, and (3) Investigation of non-invasive neuromodulation approaches for pediatric voiding disorders. His work consistently bridges clinical practice with outcomes research using both prospective trials and large database analyses. Dr. Lau maintains dual board certification through the American Board of Urology in both General Urology and Pediatric Urology subspecialty. He actively contributes to quality improvement as a member of Primary Children's Medical Center's Surgical Quality and Safety Committee. His clinical practice demonstrates exceptional patient satisfaction with a 4.9/5 rating from 97 patient reviews, consistently highlighting his ability to explain complex procedures and alleviate parental anxiety. Dr. Lau's career trajectory shows progression from fellowship training directly into faculty position at the University of Utah, where he has developed specialized clinical programs in pediatric reconstructive surgery.
Thomas Edward Ahlering is a Professor and Vice Chair in the Department of Urology at the University of California, Irvine School of Medicine . His research focuses on urologic oncology , particularly in prostate cancer and bladder cancer , with significant work on hormonal influences and surgical outcomes.
Vincent Groenhuis is a postdoctoral researcher at the Robotics and Mechatronics (EEMCS-EE-RAM) group , University of Twente. He holds a BSc, MSc, and PhD in Computer Science, Embedded Systems, and Medical Robotics respectively, all cum laude. His work focuses on image-guided medical robotics for bladder cancer diagnosis (Next-gen In-Vivo project) and MRI/ultrasound-guided breast biopsy (Sunram/MURAB projects), alongside innovations in pneumatic and electric stepper motors with two patents spun into companies. Education : BSc Computer Science (cum laude), MSc Embedded Systems (cum laude), PhD Medical Robotics (cum laude) Key Collaborations : Hamlyn Surgical Robot Challenge, European Robotic Forum, ICRA, BioRob, IROS His research integrates 3D-printed actuators with MRI safety protocols, enabling compact, reconfigurable systems for endovascular interventions and biopsy procedures. Article trends emphasize sensorless positioning , pneumatic computation , and multi-axis motor design . Awards include Best Video (Sunram 4, Hamlyn 2017) and Best Design (Sunram 3, Hamlyn 2016) . Supervised student projects span ultrasound needle steering , auto-rewind spool holders , and emergency disengagement mechanisms .
Dr Charlotte Phelps is a Senior Teaching Fellow at Bond University's Faculty of Health Sciences & Medicine and a member of the Centre for Urology Research. She holds a PhD in Physiology and Pharmacology (2024) and a Bachelor of Health Science with First Class Honours in Medical Education (2021). Her research focuses on enhancing physiology and anatomical education through hands-on methods, particularly in medical and biomedical programs. She also investigates urinary bladder physiology and urology-related topics. Education: PhD in Physiology and Pharmacology, Bond University (2024) Bachelor of Health Science with First Class Honours in Medical Education, Bond University (2021) Bachelor of Biomedical Science, Bond University (2019) Research Interests: Physiology education innovation, anatomical teaching methods, urinary bladder dysfunction, and sustainable curriculum integration. She explores technologies like augmented reality and holograms to improve student engagement and knowledge retention. Professional Activities: Member of the Australian and New Zealand Continence Journal editorial board (2023–present) Co-supervisor for a PhD candidate investigating microRNA roles in physical activity (2024–2025) Delivered invited talks on topics including planetary health education and technology-enhanced learning (2022–2024) Labs/Teams: Collaborates within the Centre for Urology Research and interdisciplinary medical education teams. Active in developing blended learning approaches using mixed reality technologies.
Dr Christian Moro is an Associate Professor in Biomedical Sciences and Medicine and Associate Dean of External Engagement at Bond University's Faculty of Health Sciences & Medicine. He is a globally recognized educator and researcher with over 200 peer-reviewed publications and accolades including the 2023 Queensland Government Tall Poppy Award and 2021 Reimagine Education Award. BSc in Biochemistry, University of Queensland (2013) PhD in Physiology & Pharmacology, Bond University (2013) MBus in Applied Finance, University of Southern Queensland (2008) BEd in Biology/Chemistry, University of Queensland (2003) His research spans urinary bladder physiology (urothelium, incontinence), pharmacological target identification, and innovative educational technologies (augmented reality, gamification). He has secured grants from government and industry partners. Recent publications highlight discoveries in bladder pharmacology, UTI management, and educational technology integration. These works reflect his dual expertise in clinical physiology and pedagogical innovation. Queensland Government Tall Poppy award (2023) Reimagine Education Teaching Award (2021) AAUT Teaching Excellence award (2020) AFR Higher Education Award (2019) AOLT Citation for Student Learning (2018) Dr Moro supervises PhD students and non-HDR projects in physiology and medical education. He leads the Mixed Reality Research Lab and contributes to the UN Sustainable Development Goals in education and health. His email is cmoro@bond.edu.au .
